CEO, INNOVA VASCULAR
WHY:Leads medical device startup focused on development treatments for cardiovascular clots. Board member and cofounder of BlackSwan Vascular, which Grand Pharmaceutical Group Ltd. acquired in April for $37.5M.
IN THE NEWS:FDA approved Innova’s Laguna Thrombectomy System, a blood clot removal device. Medical device company Cardiovascular Systems in 2021 secured the right to acquire Laguna, before it was acquired by Abbott Laboratories.
QUOTABLE:Strives to make medical procedures as easy and seamless as getting one’s teeth cleaned, since “people don’t get things treated because they are afraid of complications.”
